POORLY DIFFERENTIATED THYROID CARCINOMA
Clinical trials for POORLY DIFFERENTIATED THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new POORLY DIFFERENTIATED THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for POORLY DIFFERENTIATED THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets Hard-to-Treat cancers in first human study
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [177Lu]Lu-AKIR001, in 15 adults with advanced solid tumors (like thyroid, head and neck, cervical, vulvar, or lung cancer) that have a specific marker called CD44v6 and have stopped responding to standard treatments. The main g…
Matched conditions: POORLY DIFFERENTIATED THYROID CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New hope for tough thyroid cancers: drug combo trial launches
Disease control Recruiting nowThis study tests two drugs—sacituzumab tirumotecan alone or with tislelizumab—in people with advanced thyroid cancers that are hard to treat. The goal is to see if these treatments can shrink tumors or help people live longer. About 94 adults with anaplastic, poorly differentiate…
Matched conditions: POORLY DIFFERENTIATED THYROID CARCINOMA
Phase: NA • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 26, 2026 08:20 UTC